`

Tagged: Simplifying Clinical Research

A recent posting by Value Market Research highlighted BBCR Consulting among others relating to the global oncology Biomarker market and its projected broad growth.

December 14th, 2022 | Simplifying Clinical Research

BBCR=Simplifying Clinical Research Interest is increasing rapidly in using surrogate markers as primary measures of the effectiveness of investigational drugs in definitive drug trials. The primary difference between a biomarker and a surrogate marker is that a biomarker is a “candidate” surrogate marker. In contrast, a surrogate marker is a test used and taken to […]

Pin It on Pinterest